Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer

Table 2 Laboratory indicators of patients before and after operation [median (P25, P75)]

Laboratory indicators	D-TACE (15 cases)	C-TACE (58 cases)	χ2 value	P value
AST changes before and after surgery (U/L)	44.1 (10.4, 153.0)	102.7 (52.4, 254.8)	-2.086	0.05
ALT changes before and after surgery (U/L)	133.1 (31.6, 181.8)	110.3 (46.5, 309.7)	-1.382	0.176
TBil changes before and after surgery (μmol/L)	7.9 (5.4, 14.9)	11.6 (5.8, 21.6)	-1.842	0.081
ALB changes before and after surgery (g/L)	4.9 (3.2, 5.4)	2.6 (0.3, 5.3)	1.992	0.055
WBC changes before and after surgery (× 109/L)	2.0 (0.9, 3.9)	2.1 (1.0, 4.4)	-0.214	0.832
RBC changes before and after surgery (× 1012/L)	0.3 (0.1, 0.5)	0.0 (-0.2, 0.3)	1.995	0.058
PLT changes before and after surgery (× 109/L)	30.0 (9.0, 43.5)	36.0 (16.5, 59.2)	-1.616	0.120
AFP changes 1 mo before and after surgery (ng/mL)	0.8 (-0.3, 31.9)	19.0 (0.0, 554.6)	-1.219	0.228

D-TACE: Drug-loaded microspheres transcatheter arterial chemoembolization; C-TACE: Traditional/conventional transcatheter arterial chemoembolization; AST: Aspartate aminotransferase; ALT: Alanine transaminase; TBil: Total bilirubin; ALB: Albumin; WBC: White blood cell; RBC: Red blood cell; PLT: Platelet; AFP: Alpha fetoprotein.